Bristol Myers Squibb and Johnson & Johnson have begun an educational campaign about the factor XIa pathway, laying the groundwork for a launch that could follow phase 3 readouts expected this year.

Bayer has linked asundexian to a 26% reduction in stroke in a phase 3 study, setting the bar for Bristol Myers Squibb and Johnson & Johnson’s rival factor XIa inhibitor in a blockbuster indication.

Shares of Chinese solar panel makers surged Wednesday. Staff linked to Elon Musk had reportedly visited several photovoltaic suppliers in China. The reports had fueled speculation for potential ...

OXB, a U.K.-based cell and gene therapy manufacturer, expanded its ongoing partnership with Bristol Myers Squibb to supply lentiviral vectors for the pharma giant’s CAR-T programs. The newly expanded ...

A rapidly growing sunspot has fired off at least 18 M-class and three X-class flares in just 24 hours, including an intense X8.3 eruption. When you purchase through links on our site, we may earn an ...

As electricity prices soar and rooftop solar subsidies vanish, some US renters and homeowners are surreptitiously installing solar panels on balconies and backyards without their utility’s permission.

Last year, a viral drone video from China’s Guizhou province revealed an entire mountain range blanketed in solar panels stretching to the horizon. It’s a stunning visual, but it doesn’t even begin to ...

Federal agencies are delaying approvals for renewable energy projects on both federal land and private property at a time when electricity demand is going up. By Brad Plumer and Rebecca F. Elliott A ...

Expiration of 30% federal homeowner tax credit triggers downturn and layoffs in residential solar Installations forecast to drop sharply in 2026, delaying industry recovery Installers shifting to ...

In the residential solar sector, the industry has long sought the “holy grail” of vertical integration, creating a single point of contact for hardware, software, and energy management. While Tesla ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Bristol-Myers Squibb (BMS) reported stronger-than-expected earnings for the fourth quarter of 2025, with earnings per share (EPS) reaching $1.26, surpassing the anticipated $1.12. Revenue also ...